AI Verdict
ABT has stronger fundamentals based on our AI analysis.
ABT vs CVS Fundamental Comparison
| Metric | ABT | CVS |
|---|---|---|
| Revenue | $44.3B | $402.1B |
| Net Income | $6.5B | $1.8B |
| Net Margin | 14.7% | 0.4% |
| ROE | 12.5% | 2.4% |
| ROA | 7.5% | 0.7% |
| Current Ratio | 1.58x | 0.84x |
| Debt/Equity | 0.25x | 0.85x |
| EPS | $3.72 | $1.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs CVS: Frequently Asked Questions
Is ABT or CVS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ABT has stronger fundamentals. ABT is rated BUY (77% confidence) while CVS is rated HOLD (70% confidence). This is not investment advice.
How does ABT compare to CVS fundamentally?
ABBOTT LABORATORIES has ROE of 12.5% vs CVS HEALTH Corp's 2.4%. Net margins are 14.7% vs 0.4% respectively.
Which stock pays higher dividends, ABT or CVS?
ABT has a dividend yield of N/A or no dividend while CVS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or CVS for long term?
For long-term investing, consider that ABT has BUY rating with 77% confidence, while CVS has HOLD rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs CVS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs CVS, the AI consensus favors ABT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.